TICKERNERD
Menu
SKINSKINConsumer Defensive · Household & Personal Products

SKIN Stock Forecast: Skinhealth Systems, Inc. Price Predictions for 2026-2027

Last close, 2 Oct 2026
$0.63
0.00% on the day

The 9 Wall Street analysts covering Skinhealth Systems, Inc. hold a median 12-month price target of $0.95 — +50.8% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 78 of 100 as at 2 Oct 2026 — inside the top quartile. Here, the model and the Street point the same way.

Market cap
$82.0M
Ticker Nerd rank
78 / 100
Median analyst target
$0.95
Analysts covering
9
Revenue$72.1M−7.8% y/y
Operating income$3.6M
Net income−$2.7M
Free cash flow$1.5M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
−5.3%
1M
−10.9%
YTD
−54.7%
1Y
−62.9%
From 52W high
−62.9%
From 52W low
+8.6%
$0.58
$1.70
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

SKIN stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Skinhealth Systems, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 2 Oct 2026
78 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Accruals
94
Value
85
Quality
85
Issuance
81
Size
77
Growth
54
Revisions
33
Momentum
26
Volatility
21

Accruals (94): Reported profit is backed by cash, and the company is not expanding recklessly.

Volatility (21): The share price moves around a lot.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

SKIN stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on SKIN, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$0.60$0.80$1.00$1.20$1.40$1.60$1.80Jan 26Apr 26Jul 26Oct 26SKINHigh $1.50Median $0.95Low $0.70

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says9 analysts
1 Buy6 Hold2 Sell
Low $0.70Median $0.95High $1.50

The green dot is the last close — the median target sits +50.8% from it.

Recent analyst actionsNewest first
DateFirmActionRatingTarget
12 Aug 2026TD CowenMaintainsHold$1.00 → $0.90
20 May 2026Roth CapitalReiteratesBuy$2.50 → $2.00
20 May 2026Roth CapitalReiteratesBuy—
1 May 2026Canaccord GenuityMaintainsHold—
16 Mar 2026TD CowenMaintainsHold—
13 Mar 2026Canaccord GenuityMaintainsHold—
21 Jan 2026TD CowenMaintainsHold—
14 Jan 2026JefferiesAssumesHold$1.60
22 Sept 2025TD CowenMaintainsHold—
19 Sept 2025Roth CapitalInitiatesBuy—
1 Aug 2025StifelMaintainsHold—
5 May 2025Canaccord GenuityMaintainsHold—
13 Mar 2025Canaccord GenuityMaintainsHold—
13 Nov 2024Canaccord GenuityMaintainsHold—
12 Aug 2024Canaccord GenuityMaintainsHold—
9 Aug 2024Piper SandlerReiteratesUnderweight—
26 July 2024StifelMaintainsHold—
11 July 2024Piper SandlerMaintainsUnderweight—
13 May 2024DA DavidsonMaintainsBuy—
13 May 2024TD CowenMaintainsHold—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. SKIN appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Performance

SKIN vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 2 Oct 2026, Skinhealth Systems, Inc. returned −62.9% against +16.2% for the S&P 500, dividends included.

SKIN vs S&P 500, last 12 monthsTotal return, rebased to 100
20406080100120Jan 26Apr 26Jul 26Oct 26SKINS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

SKIN analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
+18.2%
Analysts raising
1
Analysts cutting
0
Fundamentals

Skinhealth Systems, Inc. (SKIN) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
−8.0×

Cheaper than 92% of US stocks

Price / sales
0.3×

Cheaper than 89% of US stocks

Price / book
1.5×

Cheaper than 54% of US stocks

EV / EBITDA
12.2×

Cheaper than 30% of US stocks

Growth & margins
Revenue growth (YoY)
−7.8%

Higher than 17% of US stocks

Earnings growth (YoY)
−7.8%

Higher than 28% of US stocks

Gross margin
68.4%

Higher than 81% of US stocks

Operating margin
5.0%

Higher than 55% of US stocks

Net margin
−9.8%

Higher than 20% of US stocks

Returns & dividend
Return on equity
−43.9%

Higher than 23% of US stocks

Return on assets
−0.5%

Higher than 41% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

Skinhealth Systems, Inc. (SKIN) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Skinhealth Systems, Inc. has a market value of $82.0M and an enterprise value of $245.0M.

  • Revenue in the twelve months to 30 June 2026: $290.0M. The latest quarter shrank 7.8% year on year.

  • Net income over the same four quarters: −$28.4M, a −9.8% net margin.

  • Diluted earnings per share, trailing twelve months: $−0.22.

  • Free cash flow in the twelve months to 30 June 2026: $16.6M.

  • Shares outstanding: 130.1M.

  • Trailing P/E: −8.0×; forward P/E: 3.3× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Skinhealth Systems, Inc. employs 613 people — $473K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 3 Oct 2026

Data provided by Twelve Data

Peers

SKIN vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelHousehold & Personal Products
CompanyMarket capTKN rank
SKINSkinhealth Systems, Inc.$82.0M
78
SLSNSolesence, Inc.$57.9M
32
WALDWaldencast plc$115.0M
61
GROVGrove Collaborative Holdings, Inc.$43.7M
92
UGUnited-Guardian, Inc.$32.8M
91
DSYBig Tree Cloud Holdings Ltd.$29.4M
5
NUSNu Skin Enterprises, Inc.$226.7M
65

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Skinhealth Systems, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest SKIN news & analysis

SkinHealth Systems Expands SkinStylus® SteriLock® MicroSystem to Europe

GlobeNewsWire · 1 Oct 2026positive

SkinHealth Systems (Nasdaq: SKIN), the company behind Hydrafacial™, announced the European expansion of its SkinStylus® SteriLock® MicroSystem, a professional microneedling and nano-needling device intended for cosmetic use.

Why it matters — A SKIN watcher would care because expanding the professional device portfolio into Europe broadens the company's international market presence for its flagship-brand-adjacent systems.

SkinHealth Systems Unveils New Hydrafacial™ and HydraScalp® with Keravive™ Clinical Data at the 2026 Science of Skin Summit

GlobeNewsWire · 15 Sept 2026positive

SkinHealth Systems announced that findings from two new clinical studies evaluating HydraScalp with Keravive and Hydrafacial treatments will be presented at the Science of Skin Summit, September 17-20, 2026, in Austin, Texas. The studies showed improvements in scalp and skin hydration and overall quality, including across all Fitzpatrick skin types I-VI.

Why it matters — SKIN watchers would care because positive clinical data for the company's flagship Hydrafacial brand could support its reputation and product credibility in the dermatology space.

Hydrafacial Expands Treatment Personalization and Elevates Results with Two New Treatment Enhancers

GlobeNewsWire · 8 Sept 2026positive

Hydrafacial, part of SkinHealth Systems (Nasdaq: SKIN), announced the launch of two new Treatment Enhancers: HydraGlow Pre-Extraction Peel and Hydralock HA Biocellulose Mask. The new products are designed to expand treatment personalization and elevate results.

Why it matters — New product launches expand Hydrafacial's treatment offerings and could broaden its appeal to practitioners and clients, making the innovation relevant to SKIN's growth prospects.

SkinHealth Systems Launches Hydrafacial Impact to Help Providers Accelerate Practice Growth

GlobeNewsWire · 26 Aug 2026positive

SkinHealth Systems announced the launch of Hydrafacial Impact, a national nine-city education series that expands Hydrafacial's provider training platform to help providers accelerate practice growth.

Why it matters — A SKIN watcher would care because this expands Hydrafacial's provider training offerings, which could boost provider adoption and utilization of its products.

SkinHealth Systems Inc. (SKIN) International Revenue Performance Explored

Zacks Investment Research · 11 Aug 2026neutral

Zacks Investment Research examines the evolution of SkinHealth Systems Inc.'s (SKIN) overseas revenue trends and how these international sales patterns affect Wall Street's forecasts and the stock's prospects.

Why it matters — A SKIN watcher would care because the company's international revenue performance can influence analyst forecasts and the stock's outlook.

FAQ

Frequently asked questions about SKIN stock

What is the SKIN stock price forecast for 2026-2027?

The 9 Wall Street analysts covering Skinhealth Systems, Inc. have a median 12-month price target of $0.95, with estimates ranging from $0.7 to $1.5. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is SKIN stock a buy right now?

Of the 9 analysts covering Skinhealth Systems, Inc., 1 rate it a Buy, 6 a Hold and 2 a Sell. Ticker Nerd's systematic factor model ranks Skinhealth Systems, Inc. 78 out of 100 across roughly 4,600 US stocks as at 2 Oct 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank SKIN?

As at 2 Oct 2026, Skinhealth Systems, Inc. ranks 78 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Accruals (94 of 100).

Will SKIN stock go up?

No one can know that. What the data says: the median 12-month target from 9 analysts implies +50.8% from the last close, and Ticker Nerd's factor model ranks Skinhealth Systems, Inc. 78 out of 100 as at 2 Oct 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the SKIN stock forecast for 2030?

No analyst covering Skinhealth Systems, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for SKIN are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $0.7 to $1.5 over the next 12 months.

How has SKIN stock performed over the past year?

Skinhealth Systems, Inc. returned -62.9% over the 12 months to 2 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Skinhealth Systems, Inc. do?

SkinHealth Systems Inc. Class A Common Stock represents equity in SkinHealth Systems Inc., a global medical aesthetics company focused on professional skin-care and treatment technologies.

What is the latest news on SKIN?

The most recent item we track (GlobeNewsWire, 1 Oct 2026): "SkinHealth Systems Expands SkinStylus® SteriLock® MicroSystem to Europe". SkinHealth Systems (Nasdaq: SKIN), the company behind Hydrafacial™, announced the European expansion of its SkinStylus® SteriLock® MicroSystem, a professional microneedling and nano-needling device intended for cosmetic use.

Company

About Skinhealth Systems, Inc.

SkinHealth Systems Inc. Class A Common Stock represents equity in SkinHealth Systems Inc., a global medical aesthetics company focused on professional skin-care and treatment technologies. SkinHealth Systems develops and markets an integrated portfolio centered on HydraFacial, its flagship skin treatment platform, alongside complementary offerings such as SkinStylus microneedling and HydraScalp with Keravive. The company serves clinics and providers through devices, consumables, and clinically validated treatment systems designed for use in aesthetic and dermatology-focused practices. Its products are distributed across multiple international regions, supporting a broad professional network in the skin-health market. SkinHealth Systems Inc. is headquartered in Long Beach, California, and its Class A Common Stock gives investors exposure to a business operating at the intersection of medical aesthetics, skincare technology, and provider-based treatment services.

CEO Mr. Pedro Malha · 613 employees · United States · https://www.skinhealthsystems.com